A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Completed · Phase 1

Conditions studied: Healthy Participants

In brief

The purpose of this study is to assess the pharmacokinetics (PK), safety and tolerability of different oral formulations of AZD5004, and to evaluate the effect of food on these formulations in healthy participants.

Key facts

Study ID

NCT07455825

Run by

AstraZeneca

People needed

65

Starts

2026-03-05

Expected to finish

2026-06-01

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Research Site — Glendale, California, United States
• Research Site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.